Literature DB >> 3465969

Leukotriene C4 and D4 contract rat glomerular mesangial cells.

M S Simonson, M J Dunn.   

Abstract

The sulfidopeptide leukotrienes, LTC4 and LTD4, have vasoconstrictor effects in the kidney, reducing both renal blood flow and the glomerular filtration rate. As one mechanism regulating the glomerular filtration rate, mesangial cell contraction may reduce the capillary surface area, thereby lowering the ultrafiltration coefficient. Using image analysis microscopy to quantify changes in cell morphology, we found that LTC4 and LTD4 (1 X 10(-12)M to 1 X 10(-6)M) reduced the cross-sectional area of cultured mesangial cells from rat glomeruli. The response to LTC4 and LTD4 (10(-6)M), as measured by the percentage of responding cells (30 to 35%), the maximum decrease in cross-sectional area (25 to 32%), and the time course was identical to that for angiotensin II (10(-6)M). The contraction induced by LTD4 was attenuated by an LTD4 receptor antagonist (4R,5S,6Z-nor-LTD1). Also, preincubation with colchicine prevented LTC4-induced contraction. Leukotriene B4, a non-sulfidopeptide leukotriene that stimulates chemotaxis and chemokinesis, had negligible agonist activity. Mesangial cells cultured on less adhesive teflon membranes were more responsive to LTD4 (62% of cells responded) than cells cultured on glass or polystyrene (35% of cells responded). Mesangial cell contraction was not merely a shape-change as a result of cell damage, since cellular injury was not documented by lactate dehydrogenase release and proliferation of mesangial cells was not retarded by LTC4. Furthermore, the contraction was independent of cell size. Because leukotrienes stimulate cyclooxygenase products in other cells, we examined the ability of the sulfidopeptide leukotrienes to stimulate prostaglandin and thromboxane synthesis. LTC4 and LTD4 did not stimulate PGE2 formation, the major cyclooxygenase product of rat mesangial cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465969     DOI: 10.1038/ki.1986.217

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  The role of eicosanoids in the control of mesangial function.

Authors:  M J Dunn; M S Simonson; P Mené
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

2.  Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo.

Authors:  M Elger; D Drenckhahn; R Nobiling; P Mundel; W Kriz
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

3.  Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation.

Authors:  M S Simonson; M J Dunn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.

Authors:  K F Badr; D K DeBoer; M Schwartzberg; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Increased leukotriene B4 synthesis in immune injured rat glomeruli.

Authors:  M A Rahman; M Nakazawa; S N Emancipator; M J Dunn
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.

Authors:  B A Bresnahan; S Wu; F J Fenoy; R J Roman; E A Lianos
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist.

Authors:  K F Badr; G F Schreiner; M Wasserman; I Ichikawa
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

8.  Phospholipid derived mediators and glomerulonephritis.

Authors:  E N Wardle
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.